That "poor old soul" was probably a smart investor keeping on eye on the FDA homepage. The FDA posted a release announcing the approval that morning. The FDA probably needs to rethink this policy of surprising the market as well as the affected biotech companies with press releases when the market is open.
Market Data 
Markets 
AI
